What Moderna (MRNA)'s Flu Filing Setback and 2025 Loss Mean For Its Regulatory Path
In February 2026, Moderna reported full-year 2025 revenue of US$1.94 billion and a net loss of US$2.82 billion, while the FDA’s vaccines ...
Last updated: 2026-02-18 16:38:19 ET
In February 2026, Moderna reported full-year 2025 revenue of US$1.94 billion and a net loss of US$2.82 billion, while the FDA’s vaccines ...
Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of it...
According to FT, Nigerien officials already held discussions with interested buyers from Russia, China, the US and the UAE, but have yet to find a dea...
U.S. sanctions discussions key to Iran nuclear agreement as Deputy Foreign Minister Majid Takht-Ravanchi says ball is "in America's court"
A Subaru double-cab Ute could prove to be a perfect competitor for the Ford Maverick.